Given that the nuclear accumulation of β-catenin leads to the continuous proliferation of HCC cells through the inhibition of apoptosis [142], UAP1 may be another potential target for HCC treatment (Figure 5). This evidence concerns the gene UAP1 and hepatocellular carcinoma.